<pmc-articleset>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4">
    <!--The publisher of this article does not allow downloading of the full text in XML form.-->
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">Clin Cancer Res</journal-id>
        <journal-id journal-id-type="iso-abbrev">Clin. Cancer Res.</journal-id>
        <journal-id journal-id-type="pmc-domain-id">319</journal-id>
        <journal-id journal-id-type="pmc-domain">nihpa</journal-id>
        <journal-title-group>
          <journal-title>Clinical cancer research : an official journal of the American Association for Cancer Research</journal-title>
        </journal-title-group>
        <issn pub-type="ppub">1078-0432</issn>
        <issn pub-type="epub">1557-3265</issn>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-is-collection-domain</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-collection-title</meta-name>
            <meta-value>NIHPA Author Manuscripts</meta-value>
          </custom-meta>
        </custom-meta-group>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="pmcid">PMC4807116</article-id>
        <article-id pub-id-type="pmcid-ver">PMC4807116.1</article-id>
        <article-id pub-id-type="pmcaid">4807116</article-id>
        <article-id pub-id-type="pmcaiid">4807116</article-id>
        <article-id pub-id-type="manuscript-id">NIHMS743089</article-id>
        <article-id pub-id-type="pmid">26631609</article-id>
        <article-id pub-id-type="doi">10.1158/1078-0432.CCR-15-2867-T</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHMS743089</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHPA743089</article-id>
        <article-version article-version-type="pmc-version">1</article-version>
        <article-categories>
          <subj-group subj-group-type="heading">
            <subject>Article</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>Novel <italic toggle="yes">MYBL1</italic> gene rearrangements with recurrent <italic toggle="yes">MYBL1-NFIB</italic> fusions in salivary adenoid cystic carcinomas lacking t(6;9) translocations</article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Mitani</surname>
              <given-names initials="Y">Yoshitsugu</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="author-notes" rid="FN1">*</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Liu</surname>
              <given-names initials="B">Bin</given-names>
            </name>
            <xref ref-type="aff" rid="A2">2</xref>
            <xref ref-type="author-notes" rid="FN1">*</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Rao</surname>
              <given-names initials="PH">Pulivarthi H.</given-names>
            </name>
            <xref ref-type="aff" rid="A3">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Borra</surname>
              <given-names initials="VJ">Vishnupriya J</given-names>
            </name>
            <xref ref-type="aff" rid="A3">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Zafereo</surname>
              <given-names initials="M">Mark</given-names>
            </name>
            <xref ref-type="aff" rid="A4">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Weber</surname>
              <given-names initials="RS">Randal S.</given-names>
            </name>
            <xref ref-type="aff" rid="A4">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Kies</surname>
              <given-names initials="M">Merrill</given-names>
            </name>
            <xref ref-type="aff" rid="A5">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Lozano</surname>
              <given-names initials="G">Guillermina</given-names>
            </name>
            <xref ref-type="aff" rid="A2">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Futreal</surname>
              <given-names initials="PA">P. Andrew</given-names>
            </name>
            <xref ref-type="aff" rid="A6">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Caulin</surname>
              <given-names initials="C">Carlos</given-names>
            </name>
            <xref ref-type="aff" rid="A4">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>El-Naggar</surname>
              <given-names initials="AK">Adel K.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A4">4</xref>
          </contrib>
        </contrib-group>
        <aff id="A1"><label>1</label>Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.</aff>
        <aff id="A2"><label>2</label>Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.</aff>
        <aff id="A3"><label>3</label>Department of Pediatrics, Baylor College of Medicine, Houston, Texas.</aff>
        <aff id="A4"><label>4</label>Department of Head &amp; Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.</aff>
        <aff id="A5"><label>5</label>Department of Thoracic/Head &amp; Neck Medicine Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.</aff>
        <aff id="A6"><label>6</label>Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.</aff>
        <author-notes>
          <corresp id="cor1"><bold>Corresponding Authors:</bold> Adel K. El-Naggar, Department of Pathology, Unit 85, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030. Phone: 713-792-3109; Fax: 713-792-5532; <email>anaggar@mdanderson.org</email> Or Carlos Caulin, Department of Head and Neck Surgery-Research, Unit 123, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009. Phone: 713-794-5603; Fax: 713-745-2234; <email>ccaulin@mdanderson.org</email></corresp>
          <fn id="FN1" fn-type="equal">
            <label>*</label>
            <p id="P1">Contributed equally to this work</p>
          </fn>
          <fn id="FN2" fn-type="conflict">
            <p id="P43"><bold>Competing Interests:</bold> The authors declare no conflict of interest</p>
          </fn>
        </author-notes>
        <pub-date pub-type="epub">
          <day>02</day>
          <month>12</month>
          <year>2015</year>
        </pub-date>
        <pub-date pub-type="ppub">
          <day>1</day>
          <month>2</month>
          <year>2016</year>
        </pub-date>
        <volume>22</volume>
        <issue>3</issue>
        <issue-id pub-id-type="pmc-issue-id">267158</issue-id>
        <fpage>725</fpage>
        <lpage>733</lpage>
        <pub-history>
          <event event-type="nihms-submitted">
            <date>
              <day>18</day>
              <month>03</month>
              <year>2016</year>
            </date>
          </event>
          <event event-type="pmc-release">
            <date>
              <day>01</day>
              <month>02</month>
              <year>2017</year>
            </date>
          </event>
          <event event-type="pmc-live">
            <date>
              <day>01</day>
              <month>02</month>
              <year>2017</year>
            </date>
          </event>
          <event event-type="pmc-last-change">
            <date iso-8601-date="2024-06-05 14:06:38.133">
              <day>05</day>
              <month>06</month>
              <year>2024</year>
            </date>
          </event>
        </pub-history>
        <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms743089.pdf"/>
        <abstract>
          <sec id="S1">
            <title>Purpose</title>
            <p id="P2">Adenoid cystic carcinoma (ACC) is an indolent salivary gland malignancy, characterized by t(6;9) translocations and <italic toggle="yes">MYB-NFIB</italic> gene fusions in approximately 50% of the tumors. The genetic alterations underlying t(6;9)-negative and t(6;9)-positive/<italic toggle="yes">MYB-NFIB</italic>-fusion negative ACC remain unknown. To uncover the genetic alterations in ACC lacking the canonical translocation and fusion transcript and identify new abnormalities in translocation positive tumors.</p>
          </sec>
          <sec id="S2">
            <title>Experimental Design</title>
            <p id="P3">We performed whole genome sequencing in 21 salivary ACCs and conducted targeted molecular analyses in a validation set (81 patients). Microarray gene expression data was also analyzed to explore the biological differences between fusion positive and negative tumors.</p>
          </sec>
          <sec id="S3">
            <title>Results</title>
            <p id="P4">We identified a novel <italic toggle="yes">MYBL1-NFIB</italic> gene fusion as a result of t(8;9) translocation and multiple rearrangements in the <italic toggle="yes">MYBL1</italic> gene in 35% of the t(6;9)-negative ACCs. All <italic toggle="yes">MYBL1</italic> alterations involved deletion of the C-terminal negative regulatory domain and were associated with high <italic toggle="yes">MYBL1</italic> expression. Reciprocal <italic toggle="yes">MYB</italic> and <italic toggle="yes">MYBL1</italic> expression was consistently found in ACCs. Additionally, 5’-<italic toggle="yes">NFIB</italic> fusions that did not involve <italic toggle="yes">MYB</italic>/<italic toggle="yes">MYBL1</italic> genes were identified in a subset of t(6;9)-positive/fusion-negative tumors. We also delineated distinct gene expression profiles in ACCs associated with the length of the <italic toggle="yes">MYB</italic> or <italic toggle="yes">MYBL1</italic> fusions, suggesting a biological importance of the C-terminal part of these fusions.</p>
          </sec>
          <sec id="S4">
            <title>Conclusion</title>
            <p id="P5">Our study defines new molecular subclasses of ACC characterized by <italic toggle="yes">MYBL1</italic> rearrangements and 5’-<italic toggle="yes">NFIB</italic> gene fusions.</p>
          </sec>
        </abstract>
        <kwd-group>
          <kwd>Salivary adenoid cystic carcinoma</kwd>
          <kwd>MYBL1</kwd>
          <kwd>NFIB</kwd>
          <kwd>MYB</kwd>
          <kwd>fusion gene</kwd>
        </kwd-group>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-status-qastatus</meta-name>
            <meta-value>0</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-live</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-embargo</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-released</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-open-access</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-olf</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-manuscript</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-legally-suppressed</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-pdf</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-supplement</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-pdf-only</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-suppress-copyright</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-real-version</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-scanned-article</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-preprint</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-in-epmc</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
        </custom-meta-group>
      </article-meta>
    </front>
  </article>
</pmc-articleset>
